Penumbra (PEN) Uninsured amount — Quarterly & Annual

Screener

Discontinued — last reported Q1 '17

Uninsured amount at other companies

ClearPoint NeuroCLPT

——

Segments

By geography

International$21.1M-17.6%

Other financials

Income statement

Revenue$374.8M+15.6%

Gross profit$253.4M+17.4%

Operating income$38.2M-5.2%

Net income$32.6M-16.9%

EPS (diluted)$0.82-18.0%

Balance sheet

Cash & equivalents$241.3M-35.8%

Total debt$216.2M-2.0%

Total equity$1.5B+21.5%

Total assets$1.9B+19.2%

Cash flow

Operating cash flow$87.0M+77.6%

CapEx$13.7M+1.5%

Free cash flow$73.3M+106%

Valuation

Market cap$12.73B+36.0%

Enterprise value$12.71B+38.7%

P/E74.4×+11.1×

P/S8.8×+1.4×

Profitability

Gross margin67.4%+3.7pp

Operating margin12.9%+9.8pp

Net margin11.8%+8.4pp

FCF margin14.6%+2.5pp

Returns & leverage

Return on equity12.7%+9.2pp

Debt / equity0.1×0.0×

Current ratio6×-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:CashUninsuredAmount.

The source filing: Penumbra’s 10-Q, filed May 9, 2017. Open the filing →

Filed: May 9, 2017, 4:59 PM EDT
Fiscal quarter: Q1 FY2017
Calendar quarter: Q1 2017
Accession: 0001321732-17-000121